Literature DB >> 28234128

Management of Primary Hyperparathyroidism: Can We Do Better?

Ahmed Sharata1, Tracy L Kelly, Yelena Rozenfeld, Chet W Hammill, Earl Schuman, James R Carlisle, Shaghayegh Aliabadi-Wahle.   

Abstract

The failure to follow national guidelines in management of various diseases has been previously established. We sought to quantify primary care providers' familiarity with primary hyperparathyroidism as it affects adherence to the 2009 National Institute of Health (NIH) consensus recommendations in treatment of primary hyperparathyroidism. A large primary care group was surveyed to determine their familiarity with the 2009 NIH consensus recommendations for management of primary hyperparathyroidism (PHPT). Retrospective review of the group's records (2009-2011) was performed to verify compliance. Survey responders included 109 clinicians, 31 per cent were familiar with all criteria for surgical intervention in asymptomatic patients and 34 per cent correctly identified appropriate surveillance testing for patients undergoing observation. Chart review identified 124 patients with PHPT. Of the patients who met NIH criteria, 34 per cent had a parathyroidectomy. Younger age, higher intact parathyroid hormone, hypercalciuria, and history of nephrolithiasis were associated with surgery in multivariable analysis. Of the observed patients, 16 per cent had appropriate surveillance studies. In conclusion, this study confirms suboptimal adherence with consensus recommendations in management of PHPT. A minority of clinicians demonstrated solid familiarity with management strategies, paralleling their treatment approach. Educational efforts may improve adherence with upcoming national recommendations.

Entities:  

Mesh:

Year:  2017        PMID: 28234128

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Authors:  F Saponaro; F Cetani; A Repaci; U Pagotto; C Cipriani; J Pepe; S Minisola; C Cipri; F Vescini; A Scillitani; A Salcuni; S Palmieri; C Eller-Vainicher; I Chiodini; B Madeo; E Kara; E Castellano; G Borretta; L Gianotti; F Romanelli; V Camozzi; A Faggiano; S Corbetta; L Cianferotti; M L Brandi; M L De Feo; A Palermo; G Vezzoli; F Maino; M Scalese; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-04-03       Impact factor: 4.256

2.  Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?

Authors:  Alex Dombrowsky; Benjamin Borg; Rongbing Xie; James K Kirklin; Herbert Chen; Courtney J Balentine
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2018-12-12

Review 3.  MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

Authors:  Jens Bollerslev; Camilla Schalin-Jäntti; Lars Rejnmark; Heide Siggelkow; Hans Morreau; Rajesh Thakker; Antonio Sitges-Serra; Filomena Cetani; Claudio Marcocci
Journal:  Eur J Endocrinol       Date:  2019-06-01       Impact factor: 6.664

4.  Racial disparities in the utilization of parathyroidectomy among patients with primary hyperparathyroidism: Evidence from a nationwide analysis of Medicare claims.

Authors:  Wilson M Alobuia; Tong Meng; Robin M Cisco; Dana T Lin; Insoo Suh; Manjula Kurella Tamura; Amber W Trickey; Electron Kebebew; Carolyn D Seib
Journal:  Surgery       Date:  2021-07-03       Impact factor: 3.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.